Hogan Lovells London-based corporate team has advised Numis Securities on their placing of £40 million of new equity in RWS Holdings plc (RWS) to institutional investors.

The funds will be used by RWS, together with a new debt facility and existing cash balances, to acquire the entire issued share capital of LUZ, Inc (Luz), a market leading life sciences translation services provider, for US$82.5 million.

Based in San Francisco with c.100 employees, LUZ services a number of the world’s leading pharmaceutical and medical device manufacturers.  The majority of LUZ’s customers operate in highly regulated and audited industries, and they place a premium on high quality translations delivered to exacting deadlines.

The Hogan Lovells team advising was led by London corporate partner Daniel Simons; with associates Fergus Gallagher and Ben Bridgland also working on the transaction.